Relmada Therapeutics (RLMD) Short Interest Ratio & Short Volume → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free RLMD Stock Alerts $4.30 -0.38 (-8.12%) (As of 04/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Relmada Therapeutics Short Interest DataCurrent Short Volume1,690,000 sharesPrevious Short Volume1,750,000 sharesChange Vs. Previous Month-3.43%Dollar Volume Sold Short$7.86 millionShort Interest Ratio / Days to Cover7.4Last Record DateMarch 31, 2024Outstanding Shares30,170,000 sharesPercentage of Shares Shorted5.60%Today's Trading Volume86,188 sharesAverage Trading Volume256,873 sharesToday's Volume Vs. Average34% Short Selling Relmada Therapeutics ? Sign up to receive the latest short interest report for Relmada Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRLMD Short Interest Over TimeRLMD Days to Cover Over TimeRLMD Percentage of Float Shorted Over Time Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story Relmada Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20241,690,000 shares $7.86 million -3.4%N/A7.4 $4.65 3/15/20241,750,000 shares $9.49 million No ChangeN/A5.4 $5.42 2/29/20241,750,000 shares $10.72 million +1.2%N/A5.5 $6.13 2/15/20241,730,000 shares $9.12 million +7.5%N/A5.6 $5.27 1/31/20241,610,000 shares $6.33 million +3.2%N/A5.6 $3.93 1/15/20241,560,000 shares $4.90 million +92.4%N/A6.3 $3.14 Get the Latest News and Ratings for RLMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023810,700 shares $3.36 million +26.9%N/A3.3 $4.14 12/15/2023638,800 shares $1.58 million -26.2%N/A3.7 $2.48 11/30/2023865,800 shares $2.14 million -1.1%N/A5.3 $2.47 11/15/2023875,200 shares $2.65 million +10.1%N/A5.6 $3.03 10/31/2023794,700 shares $2.38 million +13.4%N/A5 $2.99 10/15/2023700,900 shares $2.17 million -2.5%N/A4.6 $3.10 9/30/2023718,700 shares $2.16 million +6.1%N/A4.9 $3.00 9/15/2023677,500 shares $2.09 million +9.7%N/A4.5 $3.09 8/31/2023617,700 shares $2.09 million -10.5%N/A3.8 $3.38 8/15/2023689,800 shares $2.35 million -18.8%N/A4.1 $3.41 7/31/2023849,900 shares $2.23 million -11.0%N/A4.8 $2.62 7/15/2023954,400 shares $2.71 million -9.1%N/A5 $2.84 6/30/20231,050,000 shares $2.58 million -46.7%N/A5.2 $2.46 6/15/20231,970,000 shares $5.02 million -5.3%N/A8.7 $2.55 5/31/20232,080,000 shares $5.91 million +16.9%N/A11.3 $2.84 5/15/20231,780,000 shares $5.50 million -3.3%N/A9.1 $3.09 4/30/20231,840,000 shares $4.64 million +0.6%N/A9.1 $2.52 4/15/20231,830,000 shares $4.96 million +4.0%N/A8.5 $2.71 3/31/20231,760,000 shares $3.98 million +13.6%N/A6.6 $2.26 3/15/20231,550,000 shares $3.97 million +6.2%N/A5 $2.56 2/28/20231,460,000 shares $5.26 million -8.8%N/A2.5 $3.60 2/15/20231,600,000 shares $5.94 million No ChangeN/A2.5 $3.71 1/31/20231,600,000 shares $6.50 million -20.4%N/A2.2 $4.06 1/15/20232,010,000 shares $8.28 million +12.3%N/A2.4 $4.12 12/30/20221,790,000 shares $6.25 million +4.1%N/A1.4 $3.49 12/15/20221,720,000 shares $5.40 million -13.6%N/A1.3 $3.14 11/30/20221,990,000 shares $9.25 million -28.2%N/A1.6 $4.65 11/15/20222,770,000 shares $16.32 million -4.2%N/A2.6 $5.89 10/31/20222,890,000 shares $18.47 million -13.7%N/A2.9 $6.39 10/15/20223,350,000 shares $20.77 million -26.2%N/A3.8 $6.20 9/30/20224,540,000 shares $168.07 million +25.1%N/A12.3 $37.02 9/15/20223,630,000 shares $124.84 million +11.7%N/A11.3 $34.39 8/31/20223,250,000 shares $94.71 million +3.2%N/A11.9 $29.14 8/15/20223,150,000 shares $91.79 million +1.0%N/A12.3 $29.14You’re invited: Biggest crypto event of 2024 (Ad)During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.Just click here to sign up and be among the first to get it. RLMD Short Interest - Frequently Asked Questions What is Relmada Therapeutics' current short interest? Short interest is the volume of Relmada Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 1,690,000 shares of RLMD short. Learn More on Relmada Therapeutics' current short interest. What is a good short interest ratio for Relmada Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RLMD shares currently have a short interest ratio of 7.0. Learn More on Relmada Therapeutics's short interest ratio. Which institutional investors are shorting Relmada Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Relmada Therapeutics: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Relmada Therapeutics' short interest increasing or decreasing? Relmada Therapeutics saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 1,690,000 shares, a drop of 3.4% from the previous total of 1,750,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Relmada Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Relmada Therapeutics: GlycoMimetics, Inc. (2.47%), Amylyx Pharmaceuticals, Inc. (12.63%), Rezolute, Inc. (0.63%), Sagimet Biosciences Inc. (19.41%), I-Mab (1.45%), FibroGen, Inc. (5.65%), Spyre Therapeutics, Inc. (9.36%), Syros Pharmaceuticals, Inc. (9.89%), Karyopharm Therapeutics Inc. (19.94%), Eliem Therapeutics, Inc. (0.07%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Relmada Therapeutics stock? Short selling RLMD is an investing strategy that aims to generate trading profit from Relmada Therapeutics as its price is falling. RLMD shares are trading down $0.38 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Relmada Therapeutics? A short squeeze for Relmada Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RLMD, which in turn drives the price of the stock up even further. How often is Relmada Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RLMD, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: GlycoMimetics Short Interest Amylyx Pharmaceuticals Short Interest Rezolute Short Interest Sagimet Biosciences Short Interest I-Mab Short Interest FibroGen Short Interest Spyre Therapeutics Short Interest Syros Pharmaceuticals Short Interest Karyopharm Therapeutics Short Interest Eliem Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RLMD) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceUrgent alert: open this for a huge profit potentialTimothy SykesHow Biden has already won 2024Porter & CompanyOptions trading has suddenly become more reliable.Eagle Publishing